Answer
No. The injectable formulation is an immunostimulant used with interleukin-2 as maintenance treatment after earlier acute myeloid leukaemia therapy.
Sources for this answer
- Histamine dihydrochloride 0.5 mg/0.5 ml solution for injectionemc · SmPC Current selected SmPC · Version 1